Rein Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNTX and other ETFs, options, and stocks.About RNTX
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
RNTX Key Statistics
Stock Snapshot
Rein Therapeutics(RNTX) stock is priced at $1.17, giving the company a market capitalization of 29.97M. It carries a P/E multiple of -0.44.
On 2026-02-13, Rein Therapeutics(RNTX) stock moved within a range of $1.14 to $1.19. With shares now at $1.17, the stock is trading +2.6% above its intraday low and -1.3% below the session's peak.
Trading activity shows a volume of 23.58K, compared to an average daily volume of 88.46K.
Over the past 52 weeks, Rein Therapeutics(RNTX) stock has traded between a high of $2.96 and a low of $1.02.
Over the past 52 weeks, Rein Therapeutics(RNTX) stock has traded between a high of $2.96 and a low of $1.02.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.